192 related articles for article (PubMed ID: 20942909)
1. FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.
Ho IA; Ng WH; Lam PY
Mol Cancer; 2010 Oct; 9():270. PubMed ID: 20942909
[TBL] [Abstract][Full Text] [Related]
2. Targeting proliferating tumor cells via the transcriptional control of therapeutic genes.
Ho IA; Hui KM; Lam PY
Cancer Gene Ther; 2006 Jan; 13(1):44-52. PubMed ID: 16037822
[TBL] [Abstract][Full Text] [Related]
3. Glioma-specific and cell cycle-regulated herpes simplex virus type 1 amplicon viral vector.
Ho IA; Hui KM; Lam PY
Hum Gene Ther; 2004 May; 15(5):495-508. PubMed ID: 15144579
[TBL] [Abstract][Full Text] [Related]
4. Enhanced apoptosis of glioma cell lines is achieved by co-delivering FasL-GFP and TRAIL with a complex Ad5 vector.
Rubinchik S; Yu H; Woraratanadharm J; Voelkel-Johnson C; Norris JS; Dong JY
Cancer Gene Ther; 2003 Nov; 10(11):814-22. PubMed ID: 14605667
[TBL] [Abstract][Full Text] [Related]
5. FADD gene therapy for malignant gliomas in vitro and in vivo.
Kondo S; Ishizaka Y; Okada T; Kondo Y; Hitomi M; Tanaka Y; Haqqi T; Barnett GH; Barna BP
Hum Gene Ther; 1998 Jul; 9(11):1599-608. PubMed ID: 9694158
[TBL] [Abstract][Full Text] [Related]
6. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
[TBL] [Abstract][Full Text] [Related]
7. HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation.
Saydam O; Saydam N; Glauser DL; Pruschy M; Dinh-Van V; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
Gene Ther; 2007 Aug; 14(15):1143-51. PubMed ID: 17495946
[TBL] [Abstract][Full Text] [Related]
8. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter.
Komata T; Koga S; Hirohata S; Takakura M; Germano IM; Inoue M; Kyo S; Kondo S; Kondo Y
Int J Oncol; 2001 Nov; 19(5):1015-20. PubMed ID: 11605003
[TBL] [Abstract][Full Text] [Related]
9. Targeting human glioma cells using HSV-1 amplicon peptide display vector.
Ho IA; Miao L; Sia KC; Wang GY; Hui KM; Lam PY
Gene Ther; 2010 Feb; 17(2):250-60. PubMed ID: 19812609
[TBL] [Abstract][Full Text] [Related]
10. FasL gene knock-down therapy enhances the antiglioma immune response.
Jansen T; Tyler B; Mankowski JL; Recinos VR; Pradilla G; Legnani F; Laterra J; Olivi A
Neuro Oncol; 2010 May; 12(5):482-9. PubMed ID: 20406899
[TBL] [Abstract][Full Text] [Related]
11. Real-time imaging of TRAIL-induced apoptosis of glioma tumors in vivo.
Shah K; Tang Y; Breakefield X; Weissleder R
Oncogene; 2003 Oct; 22(44):6865-72. PubMed ID: 14534533
[TBL] [Abstract][Full Text] [Related]
12. Expression of mutant non-cleavable Fas ligand on retrovirus packaging cells causes apoptosis of immunocompetent cells and improves prodrug activation gene therapy in a malignant glioma model.
Nafe C; Cao YJ; Quinones A; Dobberstein KU; Kramm CM; Rainov NG
Life Sci; 2003 Aug; 73(14):1847-60. PubMed ID: 12888123
[TBL] [Abstract][Full Text] [Related]
13. Variability in infectivity of primary cell cultures of human brain tumors with HSV-1 amplicon vectors.
Rueger MA; Winkeler A; Miletic H; Kaestle C; Richter R; Schneider G; Hilker R; Heneka MT; Ernestus RI; Hampl JA; Fraefel C; Jacobs AH
Gene Ther; 2005 Apr; 12(7):588-96. PubMed ID: 15674397
[TBL] [Abstract][Full Text] [Related]
14. Modulation of the Fas-apoptosis-signalling pathway by functional polymorphisms at Fas, FasL and Fadd and their implication in T-cell lymphoblastic lymphoma susceptibility.
Villa-Morales M; González-Gugel E; Shahbazi MN; Santos J; Fernández-Piqueras J
Carcinogenesis; 2010 Dec; 31(12):2165-71. PubMed ID: 20889682
[TBL] [Abstract][Full Text] [Related]
15. Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling.
Han S; Meng L; Jiang Y; Cheng W; Tie X; Xia J; Wu A
Br J Cancer; 2017 May; 116(10):1302-1311. PubMed ID: 28359080
[TBL] [Abstract][Full Text] [Related]
16. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
[TBL] [Abstract][Full Text] [Related]
17. Humanized chondroitinase ABC sensitizes glioblastoma cells to temozolomide.
Jaime-Ramirez AC; Dmitrieva N; Yoo JY; Banasavadi-Siddegowda Y; Zhang J; Relation T; Bolyard C; Wojton J; Kaur B
J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28087981
[TBL] [Abstract][Full Text] [Related]
18. Green fluorescent protein as a reporter for retrovirus and helper virus-free HSV-1 amplicon vector-mediated gene transfer into neural cells in culture and in vivo.
Aboody-Guterman KS; Pechan PA; Rainov NG; Sena-Esteves M; Jacobs A; Snyder EY; Wild P; Schraner E; Tobler K; Breakefield XO; Fraefel C
Neuroreport; 1997 Dec; 8(17):3801-8. PubMed ID: 9427374
[TBL] [Abstract][Full Text] [Related]
19. Optimization of adenoviral vector-mediated transgene expression in the canine brain in vivo, and in canine glioma cells in vitro.
Candolfi M; Pluhar GE; Kroeger K; Puntel M; Curtin J; Barcia C; Muhammad AK; Xiong W; Liu C; Mondkar S; Kuoy W; Kang T; McNeil EA; Freese AB; Ohlfest JR; Moore P; Palmer D; Ng P; Young JD; Lowenstein PR; Castro MG
Neuro Oncol; 2007 Jul; 9(3):245-58. PubMed ID: 17522335
[TBL] [Abstract][Full Text] [Related]
20. Improved herpes simplex virus type 1 amplicon vectors for proportional coexpression of positron emission tomography marker and therapeutic genes.
Jacobs AH; Winkeler A; Hartung M; Slack M; Dittmar C; Kummer C; Knoess C; Galldiks N; Vollmar S; Wienhard K; Heiss WD
Hum Gene Ther; 2003 Feb; 14(3):277-97. PubMed ID: 12639307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
